在口腔状细胞癌 (OSCC) 中,阿斯素与电离辐射 (IR) 协同作用
Yuheng Du1, Yanjie Shuai1, Zhuang Liu1
1Department of Otorhinolaryngology Head and Neck Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Molecular biotechnology
|December 16, 2023
概括
阿斯坦丁可以通过诱导通过铁亡的细胞死亡来增强口腔状细胞癌 (OSCC) 的电离辐射疗法. 这种组合疗法在体内显示出显著的瘤生长抑制.
科学领域:
- 在瘤学瘤学.
- 生物化学 生化学
- 辐射疗法 辐射疗法
背景情况:
- 阿斯丁 (ATX) 具有抗氧化和抗炎性质,但其在癌症中的作用,特别是口腔状细胞癌 (OSCC),需要进一步研究.
- 了解ATX与现有的癌症治疗方法,如电离辐射 (IR) 的协同作用,对于开发新型治疗策略至关重要.
研究的目的:
- 研究阿斯塔克桑丁 (ATX) 与电离辐射 (IR) 结合在口腔状细胞癌 (OSCC) 的潜在协同效应.
- 阐明涉及联合治疗疗效的潜在机制,包括铁亡.
主要方法:
- 细胞活力和殖民地形成测定是在用ATX和/或IR治疗的OSCC细胞系 (CAL27,SCC9) 和正常口腔角质细胞 (NHOK) 上进行的.
- 测量了氧化应激的生化标志物 (甲,甲) 和铁水平.
- 西方斑块和免疫组织化学 (IHC) 用于分析与铁亡相关的蛋白质 (GPX4,SLC7A11,ACSL4).
- 在体内研究中使用异种移植小鼠模型来评估瘤生长和蛋白质表达.
主要成果:
- 阿斯塔丁抑制了OSCC细胞活力,但不能抑制正常的角质细胞.
- 与单个治疗相比,ATX和IR联合治疗显著增强了OSCC细胞死亡.
- ATX调节氧化应激标志物和铁水平,通过抑制GPX4和SLC7A11促进铁,同时调节ACSL4.4.
- 在体内,ATX和IR联合治疗最有效地抑制了瘤生长,与改变的蛋白质表达一致.
结论:
- 在OSCC治疗中,阿斯丁与电离辐射具有协同作用.
- 组合疗法似乎部分通过诱导OSCC细胞中的铁亡作用.
- 这些发现表明ATX作为一种潜在的辅助疗法来增强OSCC的IR疗效.
相关概念视频
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Mutations
37.9K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
37.9K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


